Tianjin Ringpu Bio-Technology Co.,Ltd. (SHE:300119)
China
· Delayed Price · Currency is CNY 19.38
+0.21 (1.10%)
Mar 10, 2026, 3:04 PM CST
SHE:300119 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 3,347 | 3,045 | 2,684 | 2,063 | 1,987 | 1,984 | Upgrade
|
| Other Revenue | 25.33 | 25.33 | 24.98 | 21.44 | 20.23 | 16.09 | Upgrade
|
| Revenue | 3,373 | 3,070 | 2,709 | 2,084 | 2,007 | 2,000 | Upgrade
|
| Revenue Growth (YoY) | 0.27% | 13.32% | 29.98% | 3.84% | 0.34% | 36.40% | Upgrade
|
| Cost of Revenue | 1,990 | 1,820 | 1,527 | 1,075 | 969.26 | 920.78 | Upgrade
|
| Gross Profit | 1,383 | 1,250 | 1,182 | 1,010 | 1,038 | 1,080 | Upgrade
|
| Selling, General & Admin | 696.52 | 640.33 | 584.43 | 486.89 | 529.17 | 521.48 | Upgrade
|
| Research & Development | 217.9 | 196.04 | 172.47 | 132.1 | 116.64 | 110.96 | Upgrade
|
| Other Operating Expenses | 26.15 | 21.89 | 20.04 | 20.4 | 18.97 | 18.44 | Upgrade
|
| Operating Expenses | 957.88 | 874.82 | 803.78 | 659.1 | 682.72 | 680.24 | Upgrade
|
| Operating Income | 424.79 | 375.04 | 378.65 | 350.43 | 355.16 | 399.38 | Upgrade
|
| Interest Expense | -35.65 | -31.21 | -25.42 | -28.43 | -23.82 | -27.17 | Upgrade
|
| Interest & Investment Income | 70.49 | 14.11 | 20.81 | 15.25 | 24.27 | 4.88 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.78 | 0.78 | 0.51 | 0.41 | -0.28 | -1.21 | Upgrade
|
| Other Non Operating Income (Expenses) | -5.13 | -4.63 | -6.12 | 0.43 | -3.21 | -1.25 | Upgrade
|
| EBT Excluding Unusual Items | 455.27 | 354.08 | 368.42 | 338.1 | 352.12 | 374.63 | Upgrade
|
| Gain (Loss) on Sale of Investments | 10.29 | -10.71 | 61.26 | 51.38 | 113.8 | 116.75 | Upgrade
|
| Gain (Loss) on Sale of Assets | 3.74 | -0.02 | 114.09 | -0.01 | 0.1 | -0.02 | Upgrade
|
| Asset Writedown | -0.15 | -0.14 | -0.47 | -0.11 | -9.1 | -1.34 | Upgrade
|
| Other Unusual Items | 25.07 | 25.07 | 27.89 | 22.16 | 30.88 | 20.9 | Upgrade
|
| Pretax Income | 494.21 | 368.29 | 571.19 | 413.81 | 487.79 | 510.92 | Upgrade
|
| Income Tax Expense | 49.45 | 38.46 | 56.18 | 40.04 | 54.2 | 71.43 | Upgrade
|
| Earnings From Continuing Operations | 444.77 | 329.83 | 515 | 373.77 | 433.59 | 439.49 | Upgrade
|
| Minority Interest in Earnings | -30.5 | -29.11 | -61.41 | -27.07 | -20.81 | -41.29 | Upgrade
|
| Net Income | 414.26 | 300.72 | 453.59 | 346.7 | 412.78 | 398.2 | Upgrade
|
| Net Income to Common | 414.26 | 300.72 | 453.59 | 346.7 | 412.78 | 398.2 | Upgrade
|
| Net Income Growth | -3.36% | -33.70% | 30.83% | -16.01% | 3.66% | 104.88% | Upgrade
|
| Shares Outstanding (Basic) | 456 | 460 | 464 | 463 | 402 | 396 | Upgrade
|
| Shares Outstanding (Diluted) | 456 | 460 | 464 | 463 | 402 | 396 | Upgrade
|
| Shares Change (YoY) | -1.15% | -0.69% | 0.11% | 15.06% | 1.61% | -0.28% | Upgrade
|
| EPS (Basic) | 0.91 | 0.65 | 0.98 | 0.75 | 1.03 | 1.01 | Upgrade
|
| EPS (Diluted) | 0.91 | 0.65 | 0.98 | 0.75 | 1.03 | 1.01 | Upgrade
|
| EPS Growth | -2.23% | -33.24% | 30.69% | -27.00% | 2.02% | 105.46% | Upgrade
|
| Free Cash Flow | 412.03 | 550.21 | 158.47 | 17.05 | 76.75 | 129.27 | Upgrade
|
| Free Cash Flow Per Share | 0.90 | 1.20 | 0.34 | 0.04 | 0.19 | 0.33 | Upgrade
|
| Dividend Per Share | 0.300 | 0.300 | 0.400 | 0.300 | 0.350 | 0.400 | Upgrade
|
| Dividend Growth | -25.00% | -25.00% | 33.33% | -14.29% | -12.50% | 60.00% | Upgrade
|
| Gross Margin | 41.00% | 40.71% | 43.65% | 48.44% | 51.71% | 53.97% | Upgrade
|
| Operating Margin | 12.60% | 12.22% | 13.98% | 16.81% | 17.70% | 19.96% | Upgrade
|
| Profit Margin | 12.28% | 9.80% | 16.74% | 16.63% | 20.57% | 19.91% | Upgrade
|
| Free Cash Flow Margin | 12.22% | 17.92% | 5.85% | 0.82% | 3.82% | 6.46% | Upgrade
|
| EBITDA | 657.41 | 567.43 | 517.4 | 457.89 | 439.13 | 495.13 | Upgrade
|
| EBITDA Margin | 19.49% | 18.48% | 19.10% | 21.97% | 21.88% | 24.75% | Upgrade
|
| D&A For EBITDA | 232.62 | 192.39 | 138.76 | 107.45 | 83.97 | 95.75 | Upgrade
|
| EBIT | 424.79 | 375.04 | 378.65 | 350.43 | 355.16 | 399.38 | Upgrade
|
| EBIT Margin | 12.60% | 12.22% | 13.98% | 16.81% | 17.70% | 19.96% | Upgrade
|
| Effective Tax Rate | 10.01% | 10.44% | 9.84% | 9.68% | 11.11% | 13.98% | Upgrade
|
| Revenue as Reported | 3,373 | 3,070 | 2,709 | 2,084 | 2,007 | 2,000 | Upgrade
|
| Advertising Expenses | - | 13.04 | 7.44 | 6.64 | 7.72 | 6.51 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.